\-\ Texto\\:\\ \ \(0\)\
\-\ clinical\\ montioring\\.\\ \\ follow\\ up\\ if\\ symptomatic\\.\ \(0\)\
\-\ patient\\ noted\\ to\\ have\\ a\\ 3x3cm\\ right\\ adrenal\\ mass\\ with\\ with\\ a\\ large\\ fatty\\ component\\ and\\ small\\ focal\\ areas\\ of\\ calcification\\.\ \(0\)\
\-\ adrenal\\ myelolipoma\ \(1\)\
\-\ adrenal\\ myelolipoma\ \(1\)\
\-\ adrenal\\ adenoma\\ \ \(1\)\
\-\ adrenal\\ carcinoma\\ \ \(0\)\
\-\ angiomyolipoma\\,\\ kidney\\ \ \(0\)\
\-\ lipoma\\/liposarcoma\\,\\ soft\\ tissue\ \(0\)\
\-\ 83\\ year\\ old\\ male\\ presents\\ with\\ hematuria\\ \ \(1\)\
\-\ pmhx\\:\\ \\ niddm\\,\\ htn\\,\\ hlp\\,\\ copd\\,\\ skin\\ cancer\\,\\ stroke\\,\\ macular\\ degeneration\\,\\ and\\ mycosis\\ fungoides\ \(0\)\
\-\ pshx\\:\\ \\ left\\ hip\\ replacement\\,\\ appendectomy\\,\\ laparotomy\\,\\ intestinal\\ blockade\\ repair\ \(0\)\
\-\ lesion\\ was\\ found\\ incidentally\\ on\\ this\\ patient\\ undergoing\\ ct\\ with\\ stone\\ protocol\\ to\\ determine\\ the\\ presence\\ of\\ a\\ possible\\ renal\\ or\\ ureteral\\ mass\\.\\ \\ stones\\ were\\ present\\ on\\ imaging\\ in\\ addition\\ to\\ adrenal\\ myelipoma\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adrenal\\:\\ 0\\.21455613492071202\ \(0\)\
\-\ myelolipoma\\:\\ 0\\.09988313556573086\ \(0\)\
\-\ montioring\\:\\ 0\\.07285552416501238\ \(0\)\
\-\ 3x3cm\\:\\ 0\\.07285552416501238\ \(0\)\
\-\ lipoma\\/liposarcoma\\:\\ 0\\.07285552416501238\ \(0\)\
\-\ niddm\\:\\ 0\\.07285552416501238\ \(0\)\
\-\ myelipoma\\:\\ 0\\.07285552416501238\ \(0\)\
\-\ hlp\\:\\ 0\\.06712703506947565\ \(0\)\
\-\ fungoides\\:\\ 0\\.0637760837627966\ \(0\)\
\-\ blockade\\:\\ 0\\.0637760837627966\ \(0\)\
\-\ mycosis\\:\\ 0\\.06139854597393891\ \(0\)\
\-\ macular\\:\\ 0\\.05677362210670401\ \(0\)\
\-\ pshx\\:\\ 0\\.052319105571723125\ \(0\)\
\-\ laparotomy\\:\\ 0\\.045617202958365036\ \(0\)\
\-\ 83\\:\\ 0\\.04301322736629978\ \(0\)\
\-\ angiomyolipoma\\:\\ 0\\.04257815518873431\ \(0\)\
\-\ copd\\:\\ 0\\.04236891710621952\ \(0\)\
\-\ pmhx\\:\\ 0\\.04177122568820608\ \(0\)\
\-\ appendectomy\\:\\ 0\\.04177122568820608\ \(0\)\
\-\ ureteral\\:\\ 0\\.04139550358839817\ \(0\)\
\-\ intestinal\\:\\ 0\\.040043194300945266\ \(0\)\
\-\ htn\\:\\ 0\\.0388813599982908\ \(0\)\
\-\ protocol\\:\\ 0\\.03798355965942472\ \(0\)\
\-\ stroke\\:\\ 0\\.03684966609319758\ \(0\)\
\-\ fatty\\:\\ 0\\.03664042801068278\ \(0\)\
\-\ stones\\:\\ 0\\.0363361802989248\ \(0\)\
\-\ degeneration\\:\\ 0\\.0358527405742834\ \(0\)\
\-\ determine\\:\\ 0\\.03575935582011867\ \(0\)\
\-\ stone\\:\\ 0\\.035133638285112914\ \(0\)\
\-\ undergoing\\:\\ 0\\.034632608352745675\ \(0\)\
\-\ replacement\\:\\ 0\\.034472128304339884\ \(0\)\
\-\ hematuria\\:\\ 0\\.03349871478651853\ \(0\)\
\-\ component\\:\\ 0\\.03225507056388799\ \(0\)\
\-\ incidentally\\:\\ 0\\.032015504143447886\ \(0\)\
\-\ addition\\:\\ 0\\.029938525397324695\ \(0\)\
\-\ adenoma\\:\\ 0\\.02949168885790093\ \(0\)\
\-\ repair\\:\\ 0\\.028280089897637493\ \(0\)\
\-\ hip\\:\\ 0\\.028131176629020316\ \(0\)\
\-\ symptomatic\\:\\ 0\\.028057714253671175\ \(0\)\
\-\ skin\\:\\ 0\\.02712503252263618\ \(0\)\
\-\ \\,\\:\\ 0\\.02684727922485495\ \(0\)\
\-\ calcification\\:\\ 0\\.025634591888075448\ \(0\)\
\-\ presence\\:\\ 0\\.025634591888075448\ \(0\)\
\-\ kidney\\:\\ 0\\.02487920210785132\ \(0\)\
\-\ possible\\:\\ 0\\.023784977015570846\ \(0\)\
\-\ areas\\:\\ 0\\.023763199762364188\ \(0\)\
\-\ cancer\\:\\ 0\\.02321624185425426\ \(0\)\
\-\ follow\\:\\ 0\\.022439665057408548\ \(0\)\
\-\ found\\:\\ 0\\.02225641003679432\ \(0\)\
\-\ clinical\\:\\ 0\\.02172983305839673\ \(0\)\
\-\ renal\\:\\ 0\\.02121880619386834\ \(0\)\
\-\ focal\\:\\ 0\\.02016936862924299\ \(0\)\
\-\ carcinoma\\:\\ 0\\.02001593115715592\ \(0\)\
\-\ mass\\:\\ 0\\.019643983585910157\ \(0\)\
\-\ if\\:\\ 0\\.019163168874220128\ \(0\)\
\-\ up\\:\\ 0\\.018990472322762176\ \(0\)\
\-\ \\:\\:\\ 0\\.018682228363482066\ \(0\)\
\-\ soft\\:\\ 0\\.017197741851186363\ \(0\)\
\-\ noted\\:\\ 0\\.01673901808638507\ \(0\)\
\-\ tissue\\:\\ 0\\.01673901808638507\ \(0\)\
\-\ imaging\\:\\ 0\\.016546064664922335\ \(0\)\
\-\ small\\:\\ 0\\.016269217226290236\ \(0\)\
\-\ were\\:\\ 0\\.01603542427016464\ \(0\)\
\-\ present\\:\\ 0\\.01595048556968331\ \(0\)\
\-\ large\\:\\ 0\\.015442499436620493\ \(0\)\
\-\ have\\:\\ 0\\.015292876680703239\ \(0\)\
\-\ presents\\:\\ 0\\.014426812359569635\ \(0\)\
\-\ lesion\\:\\ 0\\.014384753933888056\ \(0\)\
\-\ patient\\:\\ 0\\.01415854431266757\ \(0\)\
\-\ male\\:\\ 0\\.012770293701549366\ \(0\)\
\-\ on\\:\\ 0\\.01196514070025501\ \(0\)\
\-\ to\\:\\ 0\\.010588465498586436\ \(0\)\
\-\ ct\\:\\ 0\\.009878542590016883\ \(0\)\
\-\ a\\:\\ 0\\.009833052937651271\ \(0\)\
\-\ or\\:\\ 0\\.008277047512096757\ \(0\)\
\-\ was\\:\\ 0\\.008167582828212288\ \(0\)\
\-\ this\\:\\ 0\\.007943282754662257\ \(0\)\
\-\ year\\:\\ 0\\.007901696440272023\ \(0\)\
\-\ left\\:\\ 0\\.007901696440272023\ \(0\)\
\-\ right\\:\\ 0\\.007451501728185262\ \(0\)\
\-\ old\\:\\ 0\\.007230864436878138\ \(0\)\
\-\ with\\:\\ 0\\.003867906647599661\ \(0\)\
\-\ in\\:\\ 0\\.003482621736696322\ \(0\)\
\-\ and\\:\\ 0\\.002975355466648239\ \(0\)\
\-\ of\\:\\ 0\\.0019256826578179906\ \(0\)\
\-\ \\.\\:\\ 0\\.001466922979229185\ \(0\)\
\-\ the\\:\\ 0\\.0011425560719307917\ \(0\)\
